Recombinant DNA technology in adenovirus research
Szomolányi, E.; Nász, I.
Acta Virologica 28(1): 84-92
1984
ISSN/ISBN: 0001-723X PMID: 6143504 Document Number: 224634
A brief description of methods for cloning adenovirus genomic DNA and cDNA is presented, the use of recombinant clones in adenovirus research is illustrated by several examples, with particular emphasis on recent informations concerning the structure and function of adenovirus transforming genes.
Document emailed within 1 workday
Related Documents
Ranasinghe, L. 1983: Recombinant technology in medical research and therapeutics Ceylon Medical Journal 28(2): 57-61Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Wang, D.; Liu, M.; Wang, M.; Zhang, Y. 2008: Construction of recombinant adenovirus vector by c-myc silencing Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(8): 969-973
Lü, Y.-J.; Miao, S.-S.; Liu, W.-S.; He, H.-J.; Jia, S.-S.; He, G.-Q.; Xiang, C. 2011: Construction and confirmation of a recombinant adenovirus vector of survivin Zhonghua Zhong Liu Za Zhi 33(1): 13-17
Zou, X.; Guo, X.; Xiao, R.; Wang, M.; Lu, Z.; Hong, T. 2015: Rescue and Amplification of Recombinant Human Adenovirus Type 41 in 293 Cells Bing du Xue Bao 31(5): 515-523
Zhimning, Z.; Xue, L.ü; Jian, H.; Jian, W.; En, L. 2014: Recombinant adenovirus Ad-APN-EGFP constructing and promoting osteogenesis around implants Hua Xi Kou Qiang Yi Xue Za Zhi 32(5): 488-492
Darling, K. 1986: United States Department of Agriculture statement before the Subcommittee on Investigations and Oversight, Subcommittee on Natural Resources, Agriculture Research and Environment, Subcommittee on Science, Research and Technology, U.S. House of Representatives Committee on Science and Technology, July 23, 1986 Recombinant Dna Technical Bulletin 9(3): 195-202
Liu, W.; Zhao, D.; Wang, Z.; Li, Y.; Wang, H.; Wang, H. 2016: Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine Bing du Xue Bao 32(3): 267-272
Li, W.; Zhang, Y.; Wang, S. 2001: Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(1): 61-65
Chen, Z.; Li, T.; Hu, S.; Wang, G. 2009: Construction of recombinant adenovirus vector containing rat insulin-like growth factor 1 gene and its expression in islet beta-cells Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(5): 1067-1071
He, J.; Wang, J.; Jiang, X.; Wang, D.; Wen, L.; Dong, J.; Qu, J.; Hong, T. 2002: Expression of the main structural antigen VP6 of human rotavirus by recombinant adenovirus and immune responses induced in vivo Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(2): 109-113
Zhong, Z.-d.; Zou, P.; You, Y.; Huang, S.-a. 2004: Distribution and efficiency of recombinant adenovirus mediated hVEGF165 gene transfer in bone marrow transplanted mice Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 18(1): 35-38
Li, J.; Xia, Y.; Jiang, L.; Hu, S.; Xu, H. 1997: Inhibition of vascular smooth muscle cell proliferation by introduction of retinoblastoma gene via a recombinant adenovirus vector Chinese Medical Journal 110(12): 950-954
Yuan, Y.; He, J.-s.; Fu, Y.-h.; Zhang, M.; Tang, Q.; Li, D.-l.; Wei, W.; Qu, J.-g.; Hong, T. 2008: Construction and identification of replication deficient recombinant adenovirus encoding F gene of subgroup a human respiratory syncytial virus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 22(6): 428-430
Gallichan, W.S.; Johnson, D.C.; Graham, F.L.; Rosenthal, K.L. 1995: Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus Advances in Experimental Medicine and Biology 371b: 1581-1585
Kibuuka, H.; Kimutai, R.; Maboko, L.; Sawe, F.; Schunk, M.S.; Kroidl, A.; Shaffer, D.; Eller, L.A.; Kibaya, R.; Eller, M.A.; Schindler, K.B.; Schuetz, A.; Millard, M.; Kroll, J.; Dally, L.; Hoelscher, M.; Bailer, R.; Cox, J.H.; Marovich, M.; Birx, D.L.; Graham, B.S.; Michael, N.L.; de Souza, M.S.; Robb, M.L. 2010: A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172) Journal of Infectious Diseases 201(4): 600-607
Li, Z.; Shanmugam, N.; Katayose, D.; Huber, B.; Srivastava, S.; Cowan, K.; Seth, P. 1997: Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase Cancer Gene Therapy 4(2): 113-117
Timofeev, A.V.; Ozherelkov, S.V.; Pronin, A.V.; Deeva, A.V.; Elbert, L.B.; Stefenson, J.R. 1997: A recombinant adenovirus expressing the NS1 nonstructural protein of tick-borne encephalitis virus: some characteristics of the immunologic basis of antiviral action Voprosy Virusologii 42(5): 219-222
Krutov, A.A.; Grineva, N.I. 1992: Preparation of single-stranded E1A-oncogene DNA fragments from simian adenovirus SA7 by endonuclease hydrolysis recombinant phage M13 SS-DNA complexed with oligonucleotides, containing restriction sites Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1992(11-12): 29-32
Moudgil, K.D. 1986: Recombinant DNA technology: clinical prospects Indian Pediatrics 23(7): 489-492